Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter December 5, 2017

Emblica officinalis – Anti-obesity activity

Iram Nazish and Shahid H Ansari



Emblica officinalis Gaertn. (family-Phyllanthaceae) fruits, known commonly as amla, is extensively used in Indian traditional system of medicine for the treatment of various disorders. The ethanolic E. officinalis extract is reported to have various activity such as antidiabetic, antihyperlipidemic and antioxidant activity in experimental animals.


To evaluate anti-obesity effect of aqueous E. officinalis extract in murine model of high fat diet (HFD)-induced obesity.

Materials and methods

Male Wistar rats fed with HFD (20 g/day/rat, p.o) for a period of 42 days were used to induce obesity. Aqueous E. officinalis extract (20 mg/kg bw) administered orally to HFD-fed rats from day 8 to 50 days for a period of 42 days. Body weight gain, serum lipids, insulin and leptin parameters were measured.


Oral feeding of the aqueous E. officinalis extract (20 mg/kg) to HFD-induced obese rats for a period of 42 days resulted in significant reduction in body weight gain, insulin, leptin, lipids as compared to rats fed HFD alone. Further, the extract also showed significant increase in high density lipoprotein (HDL-C) levels.

Discussion and conclusions

These results show that aqueous E. officinalis extract possess significant anti-obesity potential.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


[1] Haslam DW, James WPT. Obesity. Lancet. 2005;366:1197–209.10.1016/S0140-6736(05)67483-116198769Search in Google Scholar

[2] Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37.10.1001/jama.298.17.202817986696Search in Google Scholar

[3] LeBlanc ES, O’Connor E, Wtitlock PD, Patnode CD, Kapka T. Effectiveness of primary care -relevant treatments for obesity in adults: a systematic evidence review for the U. S. Preventive Services Task Force. Ann Int Med. 2011;155:434–47.10.7326/0003-4819-155-7-201110040-00006Search in Google Scholar

[4] Chaput JP, St-Pierre S, Tremblay A. Currently available drugs for the treatment of obesity: sibutramine and orlistat. Mini Rev Med Chem. 2007;7:3–10.1726663210.2174/138955707779317849Search in Google Scholar

[5] Karamadoukis L, Shivashankar GH, Ludeman L, Williams AJ. An unusual complication of treatment with orlistat. Clin Nephrol. 2009;71:430–32.1935637610.5414/CNP71430Search in Google Scholar

[6] Mayer MA, Hocht C, Puyo A, Taira CA. Recent advances in obesity pharmacotherapy. Curr Clin Pharmacol. 2009;2009(4):53–61.Search in Google Scholar

[7] Rayalam S, Della-Fera MA, Baile CA. Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem. 2008;2008(19):717–26.Search in Google Scholar

[8] Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome – a review. Phytochemistry. 2009;70:11–24.1914716110.1016/j.phytochem.2008.11.011Search in Google Scholar

[9] Jain SK, Khurdiya DS. Vitamin C enrichment of fruit juice based ready-to serve beverages through blending of Indian gooseberry (Emblica officinalis Gaertn.) juice. Plant Foods Hum Nutr. 2004;59(2):63–66.1567875310.1007/s11130-004-0019-0Search in Google Scholar

[10] Suryanarayan P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis. 2007;24(13):1291–97.Search in Google Scholar

[11] Dhanalakshmi S, Devi RS, Srikumar R, Muruganandam AV, Kumar V, Manikandan S, et al. Protective effect of Triphala on cold stress-induced behavioral and biochemical abnormalities in rats. Yakugaku Zasshi. 2007;127(11):1863–67.10.1248/yakushi.127.186317978562Search in Google Scholar

[12] Anonymous. Indian Pharmacopoeia. New Delhi, India: Government of India, 1996.Search in Google Scholar

[13] Trease GE, Evans WC. Pharmacognosy. Philadelphia: Bailliere Tindal Publisher and distributer, 1989.Search in Google Scholar

[14] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.4337382Search in Google Scholar

[15] Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte DJ, Schwartz MW. Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high fat feeding. Am J Physiol Endocrinol Metab. 1999;277:659–66.10.1152/ajpendo.1999.277.4.E659Search in Google Scholar

[16] Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes. 1991;40:1397–403.10.2337/diab.40.11.13971936601Search in Google Scholar

[17] Mooradian AD, Chehade J, Hurd R, Haas MJ. Monosaccharide-enriched diets cause hyperleptinemia without hypophagia. Nutrition. 2000;16:439–41.1086990010.1016/S0899-9007(00)00229-XSearch in Google Scholar

[18] Brown JL, Spicer MT, Spicer LJ. Effect of high-fat diet on body composition and hormone responses to glucose tolerance tests. Endocrine. 2002;19:327–32.1262443410.1385/ENDO:19:3:327Search in Google Scholar

[19] K V A, Dikeakos A, Sclafani A. High Dietary Fat Promotes Syndrome X in Nonobese rats. J Nutr. 2003;133:2244–49.1284018710.1093/jn/133.7.2244Search in Google Scholar

[20] O’Shaughnessy IM, Myeres TJ, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, et al. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995;26:186–92.10.1161/01.HYP.26.1.1867607722Search in Google Scholar

[21] Gabriely I, Ma XH, Atzmon G, Rajala MW, Berg AH, Scherer P, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process. Diabetes. 2001;51:2951–58.Search in Google Scholar

[22] Alam I, Lewis K, Stephenes JW, Baxter JN. Obesity, metabolic syndrome and sleep apnoea: all proinflammatory states. Obes Rev. 2006;8:119127.Search in Google Scholar

[23] Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–70.10.1038/273769796811Search in Google Scholar

[24] Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2000;95:3584–89.10.1111/j.1572-0241.2000.03297.x11151896Search in Google Scholar

Received: 2016-5-31
Accepted: 2017-10-9
Published Online: 2017-12-5

© 2018 Walter de Gruyter GmbH, Berlin/Boston